Cellphire Therapeutics Names Angie Howerton as Vice President of Finance, Controller and Treasurer

Cellphire Therapeutics, Inc., a biotechnology company developing next-generation allogeneic cellular therapeutics for application across multiple medical indications, announced today that Angie Howerton, CPA, has joined the company as Vice President of Finance, Controller and Treasurer, effective immediately. Ms. Howerton is an experienced finance professional with a continuous improvement mindset. 

“We’re very pleased to have Angie join the Cellphire team,” said Mike Gaffney, Chief Executive Officer. “She joins us at an exciting time, and her strong finance background and experience with growth stage companies broadens our team at an important time in our evolution.”

Ms. Howerton brings 25-years of progressive experience with a range of companies.  Before joining Cellphire, she held leadership roles at ExeGi Pharma, Thermo Fisher Scientific, and MTI-GlobalStem.   

Ms. Howerton holds a Bachelor of Science in Accounting from Sullivan University and her CPA license in Maryland.